Common recognition of clinical experts on Shenling Baizhu Powder and Buzhong Yiqi Formula

Spleen and Stomach Diseases Committee of Beijing Association of Traditional Chinese Medicine

doi:10.16025/j.1674-1307.2018.07.002

您当前的位置：

首页 >

文章列表页 >

Common recognition of clinical experts on Shenling Baizhu Powder and Buzhong Yiqi Formula

更新时间：2023-04-10

- Common recognition of clinical experts on Shenling Baizhu Powder and Buzhong Yiqi Formula
- Beijing Journal of Traditional Chinese Medicine Vol. 37, Issue 7, Pages: 590-597(2018)
- 作者机构：
  
  1. 首都医科大学附属北京中医医院消化中心
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2018.07.002
  CLC：
扫描看全文
Spleen and Stomach Diseases Committee of Beijing Association of Traditional Chinese Medicine. Common recognition of clinical experts on Shenling Baizhu Powder and Buzhong Yiqi Formula. [J]. Beijing Journal of Traditional Chinese Medicine 37(7):590-597(2018)
DOI：

Spleen and Stomach Diseases Committee of Beijing Association of Traditional Chinese Medicine. Common recognition of clinical experts on Shenling Baizhu Powder and Buzhong Yiqi Formula. [J]. Beijing Journal of Traditional Chinese Medicine 37(7):590-597(2018) DOI： 10.16025/j.1674-1307.2018.07.002.

摘要

<正>中医学认为"脾"是人体消化系统结构和功能的结合体,其为后天之本、气血生化之源,主水谷精微之运化、主统血、主肌肉四肢。脾虚无以运化水谷,气血生化乏源,气机升降失司,则百病皆生。脾虚当以健脾为大法,健脾方为主方施治,其中代表方药为参苓白术散（颗粒、丸）和补中益气方（颗粒、丸）。二者是中医传统的经典方药,强调经典方的原方剂量,在临床上运用广

Abstract

关键词

参苓白术散补中益气方共识

Keywords

参苓白术散补中益气方共识

references

Views

599

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

“Recognition of‘disease-syndrome’ in the treatment of Helicobacter pylori infection by integrative medicine over the country”

Expert consensus on rational use of Chinese herbal medicine for COVID-19（First Edition）

Related Author

No data

Related Institution

北京大学第一医院中医中西医结合科

华中医药学会医院药学分会

京中医药学会人才培养工作委员会

京中医药大学临床药学重点专科联盟

华中医药学会医院药学分会京中医药学会人才培养工作委员会京中医药大学临床药学重点专科联盟

⁰